#Middle East and Africa Gastric Cancer Diagnostics Market Trend
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
Women make up for the other 50% of Tumblr’s audience.
Text
The Tissue Diagnostics Market is Segmented by Product (Instruments and Reagents, and Consumables), Technology (Immunohistochemistry, In-Situ Hybridizations, Digital Pathology and Workflow Management, and Others), Application (Breast Cancer, Prostate Cancer, Gastric Cancer, and Other Cancers), and Geography (North America (United States, Canada, and Mexico), Europe (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Middle East and Africa (GCC, South Africa, and Rest of Middle East and Africa), and South America Brazil, Argentina, and Rest of South America)).
Download Free Sample Report - Tissue Diagnostics Market
0 notes
Text
Middle East and Africa Gastric Cancer Diagnostics Market Trend
Middle East and Africa Gastric Cancer Diagnostics Market will exhibit a CAGR of 5.5% for the forecast period of 2021-2028
Middle East and Africa Gastric Cancer Diagnostics Market Analysis and Insights:
The gastric cancer diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.8% in the forecast period of 2021 to 2028 and is expected to reach USD 1,597.69 million by 2028. Rising prevalence of infectious diseases demands the novel and advanced gene therapy products, vaccines, personalized medicines among others which can be achieved by using gene sequences, thus acts as driver for the gastric cancer diagnostics market growth.
Stomach cancer is a type of cancer that starts in the stomach and spreads throughout the body. The stomach is a muscular pouch that lies immediately below your ribs in the upper part of your abdomen. Your stomach takes in and holds the food you eat before breaking it down and digesting it. Stomach cancer, commonly referred to as gastric cancer, can occur in any section of the stomach. Stomach cancers develop in the major section of the stomach in most parts of the world (stomach body). Various diagnostic tests used for diagnosis of cancer include prescreening tests, biopsy, biomarkers, imaging tests, PET/CT scan and ultrasound among others.
Increase in incidence of gastrointestinal tumors, lymphoma, and adenocarcinoma, Rise in alcohol consumptions and surge in smoking, increase in the geriatric population, strategic initiatives by key market players, recent advances in gastric cancer diagnostics is driving the market growth. However, high cost of testing and lack of sufficient financial support from health insurance policies is hampering the market growth.
Middle East and Africa gastric cancer diagnostics business report offers sustainable forward looking growth programs to ensure business success which is imperative for organizations. The report is very helpful for making a correct decision regarding the market and achieving a great success. It classifies the global market size with respect to its value & volume by manufacturers, type, application, and region. The research study and research data covered in this market report makes this document a handy resource for managers, analysts, industry experts, and other key people get ready-to-access and self-analyzed study. The finest Middle East and Africa gastric cancer diagnostics market report also measures the existing development trends and patterns along with distribution and marketing channels.
Get full Report: https://www.databridgemarketresearch.com/reports/middle-east-and-africa-gastric-cancer-diagnostics-market
Middle East and Africa Gastric Cancer Diagnostics Market Scope and Market Size:
On the basis of product type, the gastric cancer diagnostics market is segmented into instruments, reagents & consumables, and services.
On the basis of diagnostics type, the gastric cancer diagnostics market is segmented into gastric (pre) cancer screening tests/physical exam and confirmatory tests.
On the basis of age group, the gastric cancer diagnostics market is segmented into adult, pediatric and geriatrics.
Middle East and Africa Gastric Cancer Diagnostics Market Country Level Analysis:
The countries covered in the Middle East and Africa gastric cancer diagnostics report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Competitive Landscape & Middle East and Africa Cancer Diagnostics Market Share Analysis:
Middle East and Africa Gastric cancer diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Middle East and Africa gastric cancer diagnostics market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
An influential Middle East and Africa Gastric cancer diagnostics market study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. With this report, not only an unskilled individual but also a professional can easily extrapolate the entire market within a few seconds. Here, market segmentation is carried out in detail based on various parameters that include applications, verticals, deployment model, end user, and geography. Middle East and Africa Gastric cancer diagnostics marketing document suggests that the market is supposed to witness growth during the forecast period due to growing demand at the end user level.
Get sample report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-gastric-cancer-diagnostics-market
Major Players:
bioMérieux SA ,
Myriad Genetics, Inc.,
F. Hoffmann-La Roche Ltd,
GENERAL ELECTRIC COMPANY,
Agilent Technologies, Inc.,
Endofotonics Pte Ltd,
Biohit Oyj, BIOCEPT, INC.
Major TOC of the Report:
Chapter One: Introduction
Chapter Two: Market Segmentation
Chapter Three: Market Overview
Chapter Four: Executive Summary
Chapter Five: Premium Insight
Chapter Six: COVID-19 Impact on Middle East and Africa Gastric cancer diagnostics Market
Get TOC here: https://www.databridgemarketresearch.com/toc/?dbmr=middle-east-and-africa-gastric-cancer-diagnostics-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
0 notes
Text
Helicobacter Pylori Testing Market Study: An Emerging Hint of Opportunity by 2032
The Helicobacter pylori testing market size is used to identify a helicobacter pylori infection in the upper part of the small intestine and stomach. The helicobacter pylori test is also used to evaluate the effectiveness of the treatment. Helicobacter pylori can cause peptic ulcers, stomach (gastric) cancer and chronic gastritis.
Helicobacter pylori testing is done to find whether an infection with helicobacter pylori bacteria is causing an ulcer or not. There are different types of helicobacter pylori testing that are performed. Amongst them some requires a sample of stool or breath while others are more invasive and requires a tissue sample obtained using an endoscopy.
Helicobacter pylori bacteria grows in the digestive tract and have a tendency to attack the stomach lining. Helicobacter pylori infections are usually harmless but they are mainly responsible for majority of ulcers in the small intestine and stomach. It is the most common infection in humans therefore there detection is important.
According to a research by CDC, helicobacter pylori causes more than 90% of duodenal ulcers and up to 80% of gastric ulcers
Helicobacter Pylori Testing Market: Drivers and Restraints
Over the forecast period, the global helicobacter pylori testing market is expected to grow steadily because of the increasing number of older population, and increased prevalence of infectious diseases and gastritis.
The growing awareness of immunodiagnostics among the people, rapid advances in technology and innovations, and increasing product approvals are expected to propel the market growth of the global helicobacter pylori testing market. However high cost of test is the prominent factors restraining the growth of global helicobacter pylori testing market.
Helicobacter Pylori Testing Market: Overview
To evaluate the effectiveness of the treatment and diagnose an infection helicobacter pylori testing is done. The tests with endoscopy is considered good tests but are invasive so they are less frequently ordered. Based on end user, the global helicobacter pylori testing is segmented into hospitals, private labs, public’s health labs and physician offices.
Helicobacter Pylori Testing Market: Regional Overview
Geographically, global helicobacter pylori testing market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to dominate global helicobacter pylori testing market over the forecast period due to high prevalence of gastritis. Western Europe is expected to be the second largest market for helicobacter pylori testing. Asia Pacific market is expected to experience delayed growth due to unawareness towards helicobacter pylori testing and low disposable income.
Helicobacter Pylori Testing Market
Key Players
Some of the players identified in global helicobacter pylori testing market include Abbott, ADI/American Diagnostica, Agilent Technologies, Bio-Rad Laboratories, Inc., Helena Laboratories, Horiba, Takara Bio, EKF Diagnostics, Exalenz Bioscience Ltd., Sekisui Diagnostics, LLC, etc.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on
Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends and Issues and Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes
North America (U.S., Canada)
Latin America (Brazil, Mexico, Rest Of Latin America)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC countries, S. Africa, N. Africa, Rest Of MEA)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Helicobacter Pylori Testing Market: Segmentation
The global helicobacter pylori testing market is classified on the basis of test type, end user and geography
On the basis of test type, the global helicobacter pylori testing market can be segmented into:
With Endoscopy
Histology
Rapid urease testing
Culture
PCR (Polymerase Chain Reaction)
Without Endoscopy
Stool/fecal antigen test
Urea breath test
H. pylori antibody testing
On the basis of end user, the global helicobacter pylori testing market can be segmented into:
Hospitals
Private Labs
Public health labs
Physician offices
For more Information @ https://www.futuremarketinsights.com/reports/helicobacter-pylori-testing-marketc
0 notes
Link
https://www.databridgemarketresearch.com/reports/middle-east-and-africa-gastric-cancer-diagnostics-market
0 notes
Text
Global Tissue Diagnostic Market Highlights and Forecasts to 2031
Tissue Diagnostic Global Market Report 2022 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography. It covers the historic period – 2016-2021, and the forecast period – 2022-2026, with additional forecasts for 2026-2031. The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
TBRC’s market report includes a chapter on the COVID-19 impact on the tissue diagnostic industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it. With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected tissue diagnostic market growth numbers from 2022-2031.
Request a Sample of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=6505&type=smp
The global tissue diagnostic market size is expected to grow from $4.27 billion in 2021 to $4.56 billion in 2022 at a compound annual growth rate (CAGR) of 6.84%. The global tissue diagnostics market share is expected to grow to $5.99 billion in 2026 at a CAGR of 7.05%.
View more on the report:
The Tissue Diagnostic Global Market Report 2022-31 by The Business Research Company evaluates tissue diagnostic market size, growth rate, drivers, tissue diagnostic industry trends, and major companies.
The tissue diagnostic market segments in the report are:
1) By Product: Consumables, Antibodies, Kits, Reagents, Probes, Instruments, Slide Staining System, Scanner, Tissue Processing System
2) By Technology: Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology and Workflow Management, Special Staining
3) By Disease: Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC)
4) By End-User: Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations
The table of contents in TBRC’s tissue diagnostic market report includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
About The Business Research Company: The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 28+ countries globally.
Get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Contact Information: The Business Research Company Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/
#market research#marketstrategy#markettrends#tbrc#thebusinessresearchcompany#marketreport#marketresearch#business#market report#market analysis
0 notes
Link
https://www.databridgemarketresearch.com/reports/middle-east-and-africa-gastric-cancer-diagnostics-market
0 notes
Text
Companion Diagnostics Market Growth, Industry Outlook & Opportunities | • F. Hoffmann-La Roche AG,Agilent Technologies, Inc.
The Companion Diagnostics market was valued at USD 3.7 billion in 2020, and it is expected to reach a value of USD 13.4 billion by 2027, at a CAGR of 12.90% over the forecast period (2022 – 2027).
The market growth is mainly because of the increase in different variants of cancer among the people. As more number of clinical trials are taking place and as the demand for next generation sequencing is high, the growth of the companion diagnostic market will also remain high. Another factor which propels such a growth is the importance of the products of this market in developing various kinds of drugs.
Get FREE sample @ https://skyquestt.com/sample-request/companion-diagnostics-market
Global Companion Diagnostics Market Segmentation
The Global Companion Diagnostics market is segmented based on Product and service, Technology, Indication, End use, and Region. Based on Product and service it is categorized into: Assay kits & Reagents, Software & Services. Based on Technology it is categorized into: Polymerase Chain Reaction (PCR) , In Situ Hybridization (ISH) , Next-Generation Sequencing (NGS), Immunohistochemistry (IHC) , Others (Multiplex Assay and Cellular Imaging Technologies). Based on Indication it is categorized into: Cardiovascular, Neurological Diseases, Breast Cancer , Lung Cancer , Colorectal Cancer , Melanoma , Gastric Cancer , Infectious Diseases , Others . Based on End use it is categorized into: Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, CROs, Others . Based on region it is categorized into: North America, Europe, Asia-Pacific, South America, and MEA.
Key players in Companion Diagnostics market are:
F. Hoffmann-La Roche AG
Agilent Technologies, Inc.
Abbott Laboratories, Inc.
QIAGEN N.V.
Danaher Corporation
Almac Group
Thermo Fisher Scientific Inc.
BioMérieux SA
Myriad Genetics, Inc.
Scope of the Report
The study provides an analysis of the Global Companion Diagnostics Market in the emerging and established markets across the globe, including North America, Europe, Asia-Pacific, South America, and Middle East & Africa. For each segment, the market sizing and forecasts have been done on the basis of value.
Key Questions addressed in this report
Which are the high-growth market segments in terms of different segment names?
What is the historical market size for the Global Companion Diagnostics Market?
What are the market forecasts and estimates for the period 2020-2027?
What are the major drivers, restraints, opportunities, and challenges in the Global Companion Diagnostics Market?
Who are the major players in the market, and what share of the market do they hold?
Who are the major players in various countries, and what share of the market do they hold?
How is the competitive landscape for the Global Companion Diagnostics Market?
What are the recent developments in the Global Companion Diagnostics Market?
What are the different strategies adopted by the major players in the market?
What are the key geographic trends, and which are the high-growth countries?
Who are the local emerging players in the Global Companion Diagnostics Market, and
how do they compete with the other players?
Speak To Analyst@
https://skyquestt.com/speak-with-analyst/companion-diagnostics-market
Table Of Content Companion Diagnostics Market1. Introduction2. Research Methodology3. Executive Summary4. Market Overview5. Porter’s Five Forces Analysis6. PESTEL Analysis7. Impact of COVID 19 on the market8. Key Mandates & Regulations9. Pricing Analysis10. Competitive Analysis11. Global Companion Diagnostics Market Value by Region and Country12. Value by Product and service13. Global Companion Diagnostics Market Value by Technology14. Global Companion Diagnostics Market Value by Indication15. Global Companion Diagnostics Market Value by End use16. Companion Diagnostics Top Players Company ProfilesGlobal Companion Diagnostics Market: Impact of COVID 19
The market was negatively impacted due to Covid-19 in the first quarter of 2020. Tier 1 and Tier 2 companies in the market have their supply chains across the globe and were affected due to the lockdowns. Suppliers have their manufacturing facilities spread across various countries across Asia Pacific, Europe, North America, South America, and RoW. The lockdown and restrictions related to social distancing implemented in these COVID-19 countries had negatively affected the supply chain of these products..
Global Companion Diagnostics Market: Regional Dynamics
In terms of the regional dynamics, the region of North America emerged to be the dominant one, this was because USA remained the major contributor to the market. This cane be attributed to the fact that USA is currently witnessing a rising cases of cancer among its population. Given the rise of cancer patients, growing research funding and investments, awareness among people regarding personalised therapies etc shows that Asia pacific will grow positively from 2020-2027.
About Us-
SkyQuest Technology Group is a Global Market Intelligence, Innovation Management & Commercialization organization that connects innovation to new markets, networks & collaborators for achieving Sustainable Development Goals.
Contact Us-
SkyQuest Technology Consulting Pvt. Ltd.
USA (+1) 617-230-0741
0 notes
Text
Global Helicobacter Pylori Diagnostics Market Size, Status and Forecast 2021-2027
Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations.
One of the key drivers witnessed in the market is the growing cost-effectiveness of diagnosis and personalized antibiotic therapy. H. pylori bacteria causes ulcer. H. pylori infection requires antibiotic therapy that includes 10-14 days treatment regimen. This treatment regimen comprises of one or two antibiotics such as amoxicillin, tetracycline, metronidazole, or clarithromycin in combination with ranitidine bismuth citrate, bismuth subsalicylate, and a proton pump inhibitor (PPI). Ulcer-related symptoms such as abdominal pain and nausea and inflammation of gastric mucosa can be cured using PPIs or H2 blockers in combination with antibiotics. The cost-effectiveness of antibiotics and the lesser duration of treatment boosts the adoption of antibiotic regimen by healthcare professionals. This in turn, will drive the demand for pre- and post-monitoring tests.
Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-helicobacter-pylori-diagnostics-2021-2027-637
In terms of geography, the Europe accounted for the majority market shares during 2017 and this mainly accounted to the growing prevalence of peptic ulcer disease and gastritis. The increasing patient pool looking for the early detection of symptoms and treatment is boosting the demand for helicobacter pylori diagnostics in the region. Owing to the continuous efforts of vendors to develop a vaccination for H. pylori infection and the introduction of improved diagnostic techniques, the market will continue to witness considerable growth in this region during the next four years as well.
The helicobacter pylori diagnostics market is characterized by the presence of major vendors and is highly competitive. These vendors compete against each other based on factors including pricing, product differentiation, and advancements in technology. Vendors are highly focusing on expanding their product portfolio and increasing investments in acquiring other players, which will help them increase their revenue shares. Additionally, they are also focusing on the development of vaccines and enhancing their presence in the regional and untapped markets.
Hospitals and clinics reduce the overall disease burden and promote health by offering immunoassays and molecular diagnostic techniques. These techniques enable the early diagnosis of infectious and lethal diseases. The patient pool suffering from infectious diseases such as bacterial diseases (enteric bacteria), cancer, and other life-threatening diseases highly rely on hospitals since they have tie-ups with research and developmental centers and research institutes.
Market Analysis and Insights: Global Helicobacter Pylori Diagnostics Market
The global Helicobacter Pylori Diagnostics market size is projected to reach US$ 976.2 million by 2027, from US$ 596.2 million in 2020, at a CAGR of 7.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Helicobacter Pylori Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Helicobacter Pylori Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Helicobacter Pylori Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Helicobacter Pylori Diagnostics market.
Global Helicobacter Pylori Diagnostics Scope and Market Size
Helicobacter Pylori Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Helicobacter Pylori Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Invasive Techniques
Non-invasive Techniques
Segment by Application
Hospitals and Clinics
Diagnostic Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sekisui Diagnostics
F. Hoffmann-La Roche
Medline Industries
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Halyard Health
Cardinal Health
Beckman Coulter
Agilent Technologies
Coris BioConcept
Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-helicobacter-pylori-diagnostics-2021-2027-637
Table of content
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Invasive Techniques 1.2.3 Non-invasive Techniques 1.3 Market by Application 1.3.1 Global Helicobacter Pylori Diagnostics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals and Clinics 1.3.3 Diagnostic Laboratories 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Helicobacter Pylori Diagnostics Market Perspective (2016-2027) 2.2 Helicobacter Pylori Diagnostics Growth Trends by Regions 2.2.1 Helicobacter Pylori Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Helicobacter Pylori Diagnostics Historic Market Share by Regions (2016-2021) 2.2.3 Helicobacter Pylori Diagnostics Forecasted Market Size by Regions (2022-2027) 2.3 Helicobacter Pylori Diagnostics Industry Dynamic 2.3.1 Helicobacter Pylori Diagnostics Market Trends 2.3.2 Helicobacter Pylori Diagnostics Market Drivers 2.3.3 Helicobacter Pylori Diagnostics Market Challenges 2.3.4 Helicobacter Pylori Diagnostics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Helicobacter Pylori Diagnostics Players by Revenue 3.1.1 Global Top Helicobacter Pylori Diagnostics Players by Revenue (2016-2021) 3.1.2 Global
CONTACT US: 276 5th Avenue, New York , NY 10001,United States International: (+1) 646 781 7170 / +91 8087042414 Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
0 notes
Text
Cancer Biomarkers Market Status And Ongoing Development Trends Reviewed In New Report
The global cancer biomarkers market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of 14.38% during the forecast period (2020−2025). Cancer biomarkers are biomolecules produced either by the tumor cells or by other cells of the body in reaction to the tumor. Biomarkers can be genes, gene products, specific cells, molecules, enzymes, or hormones which can be perceived in blood, urine, tissues, or other body fluid.
New product launches for cancer biomarkers is projected to boost growth of the market. For instance, in May 2019, Roche launched a new assay that can detect the Human Epidermal Growth Factor Receptor 2 (HER2) biomarker in breast and gastric cancer in the U.K. HER2 is an important biomarker found in breast and gastric cancers. This assay allows faster cancer detection.
Key Insights:
Latest Updates
Analyst Views
Future Outlook of the Market
Get Free PDF Brochure of this Report @ https://www.fostermarketresearch.com/product/industry/biotechnology/global-cancer-biomarkers-market/Pdf%20Brochure/
Competitive Landscape:
Key players in the global cancer biomarkers market include: Abbott Laboratories Inc., Agilent Technologies, 23andMe, Ambry Genetics, Biomerieux, Celera Corporation (Quest Diagnostics), F. Hoffmann-La Roche Ltd, Hologic Inc., Myriad Genetics, Inc., Bio-Rad Laboratories, Inc., bioMérieux, Inc., Creative Diagnostics, Illumina Inc., and Thermo Fisher Scientific among others.
Rise in reimbursement programs by government or key players is probable to enhance the market growth. For instance, in July 2018, German Federal Joint Committee (G-BA) commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to evaluate the benefits and potential harm resulting from the use of biomarker-based tests to help doctors decide whether patients with primary breast cancer should receive adjuvant chemotherapy after surgery. Once feedbacks received, company is proposed to provide reimbursements for the biomarker products.
Market Taxonomy:
By Type
Genetic Biomarkers
Protein Biomarkers
Epigenetic Biomarkers
Metabolic Biomarkers
Others
By Cancer Type
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Cervical Cancer
Liver Cancer
Others
By Application
Prognostics
Research and Development
Risk Assessment
Disease Diagnosis
By Profiling Technology
Immunoassay
Imaging Technology
Cytogenetics
OMICS Technology
Others
By End Users
Hospitals
Academic and Cancer Research Institutes
Diagnostic Laboratories
Ambulatory Surgical Centers
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Talk To Analyst @ https://www.fostermarketresearch.com/product/industry/biotechnology/global-cancer-biomarkers-market/Talk-to-Analyst/
Market Dynamics:
Rise in partnerships among the key players to obtain faster drug results is estimated to lift global cancer biomarkers market over the forecast period. For instance, in November 2018, Biocartis Group signed an agreement with AstraZeneca to receive faster lung cancer molecular diagnostic biomarker results in Europe. Under the agreement, both the companies collaborated to conduct prospective lung cancer study with Biocartis’s Idylla EGFR Mutation Test (CE-IVD) in more than 12 countries in Europe such as in Belgium, France, Germany and Italy.
However, product recalls by key players due to failure in working is projected to hinder the growth of global cancer biomarkers market during the forecast period. For instance, in October 2018, Ventana Medical Systems recalled FLO-LOK III Dispenser Detection kits due to leaking and sticking of reagent dispensers which could cause false negative results. FLO-LOK III Dispenser is used to indicate a disease state through the detection of biomarkers.
FAQ's:
Note: This report provides an in-depth analysis of the global cancer biomarkers market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.
What are the trends adopted by key players in the global cancer biomarkers market?
What key factors are expected to increase the demand for global cancer biomarkers market during the forecast period 2020-2025?
What are the major challenges inhibiting the growth of the global cancer biomarkers market?
Which type (genetic biomarkers, protein biomarkers, epigenetic biomarkers, metabolic biomarkers, and others) is expected to dominate the global cancer biomarkers market in the coming years?
Which application (prognostics, research and development, risk assessment, and disease diagnosis) is expected to propel the market in the foreseen future?
Which profiling technology (immunoassay, imaging technology, cytogenetics, OMICS technology, and others) is expected to propel the market in the forecasted future?
What is the total market value (US$ Mn) generated in the global cancer biomarkers market by cancer type in 2019, and what are the forecasts by 2025?
Buy Now This Business Strategic Report to Improve Your Profits @ https://www.fostermarketresearch.com/product/buy/biotechnology/225/
About Foster Market Research:
Foster Market Research is a global market intelligence and advisory firm engaged in providing data-driven research extract from rigorous analysis, to the clients to make critical business decisions and execute them successfully. Foster connects over various distribution channels and numerous markets for great understanding of the trends and market to deliver our clients with accurate data.
Our focus is on providing market research that delivers a positive impact on your business. We work continuously to provide our clients with the most accurate analytics data and research reports without any delay so as to improve their business strategies and provide them with rich customer experience.
Contact Us:
1701 Royal Lane, #1306, Dallas Tx-75229 Phone: +1 469 4981929 Email: [email protected]
0 notes
Text
Europe Gastric Cancer Diagnostics Market Trend
Europe Gastric Cancer Diagnostics Market will exhibit a CAGR of 6.9% for the forecast period of 2021-2028
Europe Gastric Cancer Diagnostics Market Analysis and Insights:
The gastric cancer diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.8% in the forecast period of 2021 to 2028 and is expected to reach USD 1,597.69 million by 2028. Rising prevalence of infectious diseases demands the novel and advanced gene therapy products, vaccines, personalized medicines among others which can be achieved by using gene sequences, thus acts as driver for the gastric cancer diagnostics market growth.
Stomach cancer is a type of cancer that starts in the stomach and spreads throughout the body. The stomach is a muscular pouch that lies immediately below your ribs in the upper part of your abdomen. Your stomach takes in and holds the food you eat before breaking it down and digesting it. Stomach cancer, commonly referred to as gastric cancer, can occur in any section of the stomach. Stomach cancers develop in the major section of the stomach in most parts of the world (stomach body). Various diagnostic tests used for diagnosis of cancer include prescreening tests, biopsy, biomarkers, imaging tests, PET/CT scan and ultrasound among others.
The universal Europe gastric cancer diagnostics market report helps to know how patents, licensing agreements and other legal restrictions affect the manufacture and sale of the firm’s products. With the global market data provided in the report, it has become easy to achieve global perspective for an international business. The scope of this market research report can be expanded from market scenarios to comparative pricing between major players. The market report highlights the global key manufacturers to define, describe and analyze the market competition landscape via SWOT analysis. In the credible Europe gastric cancer diagnostics marketing report, the complete and crystal clear outline of the market is penned down which is useful for many businesses.
Get full Report: https://www.databridgemarketresearch.com/reports/europe-gastric-cancer-diagnostics-market
Europe Gastric Cancer Diagnostics Market Country Level Analysis:
The countries covered in the Europe gastric cancer diagnostics report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Get sample report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-gastric-cancer-diagnostics-market
Competitive Landscape & Europe Cancer Diagnostics Market Share Analysis:
Europe Gastric cancer diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Europe gastric cancer diagnostics market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
With the comprehensive analysis of the market, global Europe Gastric cancer diagnostics market document puts forth overview of the market regarding type and applications, featuring the key business resources and key players. This market study also evaluates the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. For reaching towards the success at local, regional as well as international level, this high quality market research report is a definitive solution. The wide ranging Europe Gastric cancer diagnostics report is an entire background analysis of the industry which includes an estimation of the parental market.
Europe Gastric Cancer Diagnostics Market Scope and Market Size:
On the basis of product type, the gastric cancer diagnostics market is segmented into instruments, reagents & consumables, and services.
On the basis of diagnostics type, the gastric cancer diagnostics market is segmented into gastric (pre) cancer screening tests/physical exam and confirmatory tests.
On the basis of age group, the gastric cancer diagnostics market is segmented into adult, pediatric and geriatrics.
Reason to Buy:
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Organic Global Europe Gastric Cancer Diagnostics Market
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends thereby allowing players to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Major Players:
bioMérieux SA ,
Myriad Genetics, Inc.,
F. Hoffmann-La Roche Ltd,
GENERAL ELECTRIC COMPANY,
Agilent Technologies, Inc.,
Endofotonics Pte Ltd,
Biohit Oyj, BIOCEPT, INC.
Major TOC of the Report:
Chapter One: Introduction
Chapter Two: Market Segmentation
Chapter Three: Market Overview
Chapter Four: Executive Summary
Chapter Five: Premium Insight
Chapter Six: COVID-19 Impact on Europe Gastric cancer diagnostics Market
Get TOC here: https://www.databridgemarketresearch.com/toc/?dbmr=europe-gastric-cancer-diagnostics-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
0 notes
Text
Global Tissue Diagnostics Market Size, Share & Growth Projected to Grow at the CAGR of 7.5% by 2027 | BlueWeave
A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global tissue diagnostics market was worth USD 4.9 billion in the year 2020. The data yielded by the study further reveals that the market is estimated to grow at the CAGR of 7.5%, earning revenue of around USD 8.1 billion by the end of 2027. Changing lifestyles, increasing consumption of alcohol, along with rising awareness regarding cancer are increasing the demand for tissue diagnosis which is driving the growth of the global tissue diagnostics market forward.
Expanding Healthcare Expenditure Driving the Market Forward
The escalating healthcare expenditures from the government as well as the general public have become a primary driver of the global tissue diagnostics market. As the governments of different countries are working towards building a robust healthcare infrastructure, the number of hospitals and diagnostic centers is increasing exponentially, thereby driving the demand for tissue diagnostics. Furthermore, due to the rising per capita income of the people, they are spending more on their health. Furthermore, health-conscious people are increasingly prepared to spend money on diagnostic treatments even for minor symptoms, which is driving up market demand.
Technological Advancements in the Tissue Diagnostic Market
With the increasing prevalence of cancer, there is a greater demand for diagnostic technologies that can detect and monitor cancers in their early stages. As a result, manufacturing companies are concentrating on launching products that are both effective and automated. That is why the digital pathology sector is flourishing at a great pace. Digital pathology employs the whole-slide imaging (WSI) technology, which allows researchers and analysts to perform a quantitative study of the tissue while also allowing image sharing across remote locations. The industry is also growing due to the implementation of sophisticated technology for diagnosis and research.
Breast Cancer Segment Will Grow at a Healthy CAGR in the Forecast Period
Based on applications, the global tissue diagnostics segment is divided into several segments—breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer (NSCLC), and other diseases. Among these, the breast cancer segment is growing at the highest CAGR due to the rising prevalence of the disease among women all around the world. The rising use of advanced technologies, as well as the massive amount of research being done to better understand this issue, has been a major contributor to the growth in breast cancer diagnoses.
Global Tissue Diagnostics Market - Regional Insights
Geographically, the global tissue diagnostics market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. With the rising prevalence of cancer among its population and the provision of adequate reimbursement regulations that make diagnosis and treatment more accessible to more people, North America dominates the global tissue diagnostics market. Furthermore, with favorable government initiatives for treating cancer and expanding healthcare expenditure, the tissue diagnostics market is flourishing in this region. Following North America, Europe has a sizable portion of the global tissue diagnostics market, owing to its expanding public cancer-prevention efforts.
Impact of Covid-19 on the Global Tissue Diagnostics Market
The global tissue diagnostics industry was severely impacted during the early phases of the Covid-19 outbreak. All of the resources, both material and human, were devoted to dealing with the deadly Covid-19 cases, which were only surging with each passing day. The focus of research institutes and investments began to shift toward studying and eradicating the virus, leaving little or no room for tissue diagnostics. However, as the prevalence of cancer has spiraled up due to inadequate treatment during the Covid-19 period, the market for global tissue diagnostics is predicted to rise in the post-Covid-19 world.
Competitive Landscape
The leading market players in the global tissue diagnostics market are Abbott Laboratories, Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, BioGenex Laboratories, F. Hoffmann-La Roche Ltd, Cancer Genetics, Inc., Genomic Health, Inc., Merck KGaA, Becton, Dickinson And Company, Amos Scientific Pty Ltd, Bio Sb, Sakura Finetek Japan, Slee Medical GMBH, Cellpath Ltd, Hologic, Inc., Medite GMBH, Jinhua Yidi Medical Appliance Co. Ltd, Histo-Line Laboratories, and other prominent players.
The adoption of organic and inorganic strategies, such as partnerships, collaboration, acquisitions, etc. is highly prevalent in this market. Moreover, the companies invest a significant amount into research and development to expand their product portfolio to stay ahead in the market.
Don’t miss the business opportunity of the global tissue diagnostics market. Consult our analysts to gain crucial insights and facilitate your business growth.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the global tissue diagnostics market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends of the global tissue diagnostics market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.
About Us
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solutions. BWC has built its reputation from the scratches by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
Contact Us: BlueWeave Consulting & Research Pvt. Ltd US: +1 866 658 6826 | +1 425 320 4776 UK: +44 1865 60 0662 Email – [email protected] LinkedIn Page: https://www.linkedin.com/company/blueweaveconsulting/
#Tissue Diagnostics Market#Tissue Diagnostics Market Share#Tissue Diagnostics Market Size#Tissue Diagnostics Market Forecast
0 notes
Link
https://www.databridgemarketresearch.com/reports/global-companion-diagnostics-market
0 notes
Text
Portable Ultrasound Devices Market Analysis with COVID-19 Strategic Trends and Forecast to 2027
The research report “Global Portable Ultrasound Device Market Size, Share, Development, Growth and Demand Industry Insights - by End User (Diagnostic Center, Hospital and Others), by type (Hand-Held and Mobile), by Application (Cardiovascular, Gastric, Obstetrics and Gynecology and others), and Geography-Global/Region/Country Forecast to 2027”, The Global Portable Ultrasound Devices Market was valued at USD 4410 million in 2020 and is anticipated to reach at USD 7035 million in 2026 recording a CAGR of 13.6% during the forecast period 2021-2027.
Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on "Global Portable Ultrasound Devices Market Size, Share, Development, Growth and Demand, Industry Insights - by End User (Diagnostic Center, Hospital and Others), by type (Hand-Held and Mobile), by Application (Cardiovascular, Gastric, Obstetrics and Gynecology and others), and Geography-Global/Region/Country Forecast to 2027”.
View detailed Report Description at https://precisionbusinessinsights.com/market-reports/global-portable-ultrasound-devices-market/
Hand-held portable ultrasound device sector to drive the Portable Ultrasound Devices Market growth
Ultrasound is utilized for both the purposes such as therapeutics and diagnosis purpose. Portable ultrasound device is smaller and lighter too. It is convenient to carry and particularly used at point-of-care. The global portable ultrasound device market witnessed considerable growth owing to the prominent factors such as increasing cases of chronic diseases and huge healthcare expenses Furthermore, enhancing healthcare infrastructure in emerging economies like India and China is another market driving factor for market growth.
Increasing aged population base also elevated the occurrence of osteoporosis illness caused because of weak bones. Weak bones caused due to the lack of vitamin D and other problems in the old age will serve as a crucial factor for market growth. The ease of operating the portable ultrasound devices is another industry growing factor. Technological developments will create positive effect on the adoption rate of such devices. High-end technology is used for the production of portable devices, which increases the overall cost of these devices. High cost of such devices will negatively affect the adoption rate of such devices in both developed and under-developed countries. Strict rules for approving portable ultrasound devices are a market restraining factor. Hand-held portable ultrasound device sector is anticipated to record the fast growth during the evaluation period recording a CAGR of 13.1% worldwide.
Request a case study or sample research report at https://precisionbusinessinsights.com/request-sample?product_id=15902
Impact of COVID-19 Portable Ultrasound Device Market:
In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. Europe is anticipated to dominate the Global Portable Ultrasound Device Market
On the basis geographical analysis, the global market is categorized into North America, Europe, Middle East & Africa and Asia Pacific. Among all these regions, North America obtained the huge market revenue share in the market and is anticipated to become the biggest market during the forecast years 2121-2027 owing to the factors like growing adoption of the technologically advanced portable ultrasound and huge demand for precise medical imaging because of increasing occurrence of critical illnesses like cancer. Europe is also anticipated to dominate the market at steady level during the forecasted years. It is mainly due to the increasing occurrence of chronic illnesses in the region.
Competitive Analysis
A few of the major key players of the Global Portable Ultrasound Device Market are Shenzhen Canon Medical Systems, Mindray, Fukuda Denshi, Hitachi, GE Healthcare, Samsung Medical and Siemens Healthcare. Key players of the market are implementing different strategies to survive in the competitive market and make their position in the market.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: www.precisionbusinessinsights.com | D U N S® Number: 852781747
Email: [email protected] | Schedule a Meeting: calendly.com/satya-prabhu-pbi
0 notes
Link
https://www.databridgemarketresearch.com/reports/global-gastric-cancer-diagnostics-market
0 notes
Text
Global Cancer Tissue Diagnostics Market Challenges, Development History & Future Growth 2031 | FMI
A recent revised study by FMI on the cancer tissue diagnostics market offers a 10-year forecast from 2021 to 2031. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players associated with cancer tissue diagnostics. The study also provides the dynamics that are responsible for influencing the future status of the market over the forecast period.
A detailed assessment of the value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the cancer tissue diagnostics market, along with their product portfolios, enhances the reliability of this comprehensive research study.
Report Summary
The study offers comprehensive analysis on diverse features, including demand, product development, revenue generation, and sales of cancer tissue diagnostics across regions.
A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account sales during the forecast period. Price point comparison by region with global average price is also considered in the study.
Market Segmentation
FMI’s research study assesses the global cancer tissue diagnostics market in terms of test type and region. This report presents extensive market dynamics and trends associated with different segments of the market, and their influence on the growth prospects of the market.
Test Type
Immunohistochemical (IHC) Test
In Situ Hybridization (ISH) Test
Breast Cancer
Stomach (Gastric) Cancer
Colorectal Cancer
Prostate Cancer
Others
Breast cancer
Non-Small Cell Lung Cancer (NSCLC)
Bladder Cancer
Others
Region
North America
Latin America
Europe
Middle East and Africa (MEA)
East Asia
South Asia
Oceania
Get Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4191
Key Questions Answered in Report
Which are the most lucrative markets for cancer tissue diagnostics?
Which factors will impact demand for cancer tissue diagnostics?
How will changing trends impact the strategies of market players?
How can market players capture the low-hanging opportunities across regions?
Which companies are leading the cancer tissue diagnostics market?
What are the winning strategies of stakeholders in the cancer tissue diagnostics landscape?
Inspected Assessment on Regional Segments
Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the market during the forecast period.
Country-specific valuation on demand for cancer tissue diagnostics has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value for emerging countries has also been included in the report.
Research Methodology
In FMI’s study, a unique research methodology is utilized to conduct extensive research on the growth of the cancer tissue diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.
Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.
Any Queries, ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-4191
Reasons to Buy the report
We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.
Explore Wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape
Smart Insulin Pens Market: 2021 Analysis and Review: Smart Insulin Pens Market by Connectivity – Bluetooth Connected and USB Connected for 2021 – 2031
Zika Virus Testing Market: 2021 Analysis and Review: Zika Virus Testing Market by Test Type – Rapid IgG/ IgM Test and ELISA Test for 2021 - 2031
Dengue Vaccines Market: 2021 Analysis and Review: Dengue Vaccines Market by Product - CYD-TDV (Dengvaxia) for 2021 - 2031
About FMI
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
0 notes
Text
Global Tissue Diagnostics Market Set to Script Impressive Growth: Projected to Grow at the CAGR of 7.5% in the Forecast Period
A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global tissue diagnostics market was worth USD 4.9 billion in the year 2020. The data yielded by the study further reveals that the market is estimated to grow at the CAGR of 7.5%, earning revenue of around USD 8.1 billion by the end of 2027. Changing lifestyles, increasing consumption of alcohol, along with rising awareness regarding cancer are increasing the demand for tissue diagnosis which is driving the growth of the global tissue diagnostics market forward.
Expanding Healthcare Expenditure Driving the Market Forward
The escalating healthcare expenditures from the government as well as the general public have become a primary driver of the global tissue diagnostics market. As the governments of different countries are working towards building a robust healthcare infrastructure, the number of hospitals and diagnostic centers is increasing exponentially, thereby driving the demand for tissue diagnostics. Furthermore, due to the rising per capita income of the people, they are spending more on their health. Furthermore, health-conscious people are increasingly prepared to spend money on diagnostic treatments even for minor symptoms, which is driving up market demand.
Technological Advancements in the Tissue Diagnostic Market
With the increasing prevalence of cancer, there is a greater demand for diagnostic technologies that can detect and monitor cancers in their early stages. As a result, manufacturing companies are concentrating on launching products that are both effective and automated. That is why the digital pathology sector is flourishing at a great pace. Digital pathology employs the whole-slide imaging (WSI) technology, which allows researchers and analysts to perform a quantitative study of the tissue while also allowing image sharing across remote locations. The industry is also growing due to the implementation of sophisticated technology for diagnosis and research.
Breast Cancer Segment Will Grow at a Healthy CAGR in the Forecast Period
Based on applications, the global tissue diagnostics segment is divided into several segments—breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer (NSCLC), and other diseases. Among these, the breast cancer segment is growing at the highest CAGR due to the rising prevalence of the disease among women all around the world. The rising use of advanced technologies, as well as the massive amount of research being done to better understand this issue, has been a major contributor to the growth in breast cancer diagnoses.
Global Tissue Diagnostics Market - Regional Insights
Geographically, the global tissue diagnostics market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. With the rising prevalence of cancer among its population and the provision of adequate reimbursement regulations that make diagnosis and treatment more accessible to more people, North America dominates the global tissue diagnostics market. Furthermore, with favorable government initiatives for treating cancer and expanding healthcare expenditure, the tissue diagnostics market is flourishing in this region. Following North America, Europe has a sizable portion of the global tissue diagnostics market, owing to its expanding public cancer-prevention efforts.
Impact of Covid-19 on the Global Tissue Diagnostics Market
The global tissue diagnostics industry was severely impacted during the early phases of the Covid-19 outbreak. All of the resources, both material and human, were devoted to dealing with the deadly Covid-19 cases, which were only surging with each passing day. The focus of research institutes and investments began to shift toward studying and eradicating the virus, leaving little or no room for tissue diagnostics. However, as the prevalence of cancer has spiraled up due to inadequate treatment during the Covid-19 period, the market for global tissue diagnostics is predicted to rise in the post-Covid-19 world.
Competitive Landscape
The leading market players in the global tissue diagnostics market are Abbott Laboratories, Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, BioGenex Laboratories, F. Hoffmann-La Roche Ltd, Cancer Genetics, Inc., Genomic Health, Inc., Merck KGaA, Becton, Dickinson And Company, Amos Scientific Pty Ltd, Bio Sb, Sakura Finetek Japan, Slee Medical GMBH, Cellpath Ltd, Hologic, Inc., Medite GMBH, Jinhua Yidi Medical Appliance Co. Ltd, Histo-Line Laboratories, and other prominent players.
The adoption of organic and inorganic strategies, such as partnerships, collaboration, acquisitions, etc. is highly prevalent in this market. Moreover, the companies invest a significant amount into research and development to expand their product portfolio to stay ahead in the market.
Don’t miss the business opportunity of the global tissue diagnostics market. Consult our analysts to gain crucial insights and facilitate your business growth.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the global tissue diagnostics market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends of the global tissue diagnostics market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.
About Us
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solutions. BWC has built its reputation from the scratches by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
0 notes